- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01993121
Exercise and Type 2 Diabetes: Gender and Endothelial Function
The objective of the current proposal is to evaluate the importance of blood vessel dysfunction and heart dysfunction to overall exercise impairments in type 2 diabetes and their contribution to the gender differences observed in exercise capacity. Importantly, treatments that improve blood vessel function in persons with type 2 diabetes can be used to directly assess whether impairment in blood vessel function and ultimately exercise performance, can be improved and whether the degree of improvement differs between the sexes.
Hypothesis 1. Uncomplicated type 2 diabetes more adversely affects exercise capacity in women than men.
Hypothesis 2. Blood vessel function and cardiac function are more significantly impaired in women with type 2 diabetes than men and contribute to the gender differences in exercise capacity.
Hypothesis 3. Restoration of blood vessel function will improve exercise capacity more in women than men with type 2 diabetes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects will come in for a total of seven research visits. Four initial study visits before exercise training for three months and then subjects will repeat the testing.
- Initial exam. A history and physical exam will be performed. Blood will be drawn for measurements of overall health. Resting electrocardiogram will be obtained. The Low Level Physical Activity Recall (LOPAR) questionnaire will be administered.
- Dual Energy X-ray Absorptiometry (DEXA) will be carried out during visit two. A familiarization bicycle ergometer test will also be performed on this day.
- During visit three, a euglycemic clamp will be performed.
- During visit four, echocardiographic measurements will be made and a diet interview will be performed.
- On visit five, measures of blood vessel-dependent vasodilation will be performed. Repeated brachial artery diameter and forearm blood flow responses to cuff occlusion will be measured separately on this occasion.
- On visit six, arterial stiffness will be measured. Subjects will also perform a graded bicycle exercise test.
- On visit seven, subjects will perform constant level bicycle tests.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado, Anschutz Medical Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women between the ages of 30 and 55 years
- Persons with type 2 diabetes taking only certain oral medications (
- Pre-menopausal women
- Persons with type 2 diabetes who have a total HbA1c level <9%
- Persons with a BMI between 25-35.
Exclusion Criteria:
- Current smokers or anyone who has smoked within the last year
- Persons who have clinically evident distal symmetrical neuropathy
- Abnormal lipid levels (total cholesterol >200, LDL-cholesterol level >130, or triglyceride level >250).
- Persons with regional wall motion abnormalities, left ventricular wall thickness >1.1 cm , or decreased contractility.
- Persons will also be excluded if they have evidence of ischemic heart disease by history or abnormal resting or exercise electrocardiogram (ECG).
- Presence of systolic blood pressure >140 mmHg at rest or >250 mmHg with exercise or diastolic pressure >90 mmHg at rest or >105 mmHg with exercise will be grounds for exclusion.
- Subjects will be excluded who have peripheral arterial disease.
- Persons with autonomic insufficiency, assessed by measuring variation in RR intervals with cycled breathing and by presence of a >20 mm fall in upright blood pressure without a change in heart rate, will be excluded.
- Subjects with proteinuria (urine protein >200 mg/dl) or a creatinine > 2 mg/dl, suggestive of renal disease will be excluded.
- Controls will not be accepted with an immediate family history of Type 2 Diabetes Mellitis
Study Plan
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Three-month exercise training program
All subjects will perform three months of supervised exercise training.
|
All subjects will perform three months of supervised exercise training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline in cardiovascular exercise performance
Time Frame: baseline and 3 months
|
Subjects' peak oxygen consumption will be tested on a stationary bike before and after 3 months of exercise training.
|
baseline and 3 months
|
Changes from baseline in cardiovascular exercise performance
Time Frame: baseline and 3 months
|
Subjects' oxygen uptake kinetics will be tested on a stationary bike before and after 3 months of exercise training.
|
baseline and 3 months
|
Changes from baseline in cardiovascular exercise performance
Time Frame: baseline and 3 months
|
Subjects' tissue oxygen saturation will be tested during exercise testing before and after 3 months of exercise training.
|
baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline in endothelial function will be measured
Time Frame: baseline and 3 months
|
Endothelial-dependent vasodilation will be determined in the peripheral circulation by measurement of changes in brachial artery diameter in response to cuff occlusion.
|
baseline and 3 months
|
Changes from baseline in endothelial function will be measured
Time Frame: baseline and 3 months
|
Forearm blood flow will be assessed by plethysmography before and after cuff occlusion.
|
baseline and 3 months
|
Changes from baseline in diastolic function will be measured
Time Frame: baseline and 3 months
|
The role of diastolic function in the exercise impairments will be examined using advanced echocardiographic techniques during rest and exercise
|
baseline and 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Judith G Regensteiner, PhD, University of Colorado, Denver
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02-0514
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on Supervised Exercise Training
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease
-
Medical University of ViennaUnknownPeripheral Artery DiseaseAustria
-
Chang Gung Memorial HospitalCompleted
-
Paracelsus Medical UniversityLudwig Boltzmann Institute for Digital Health and PreventionCompleted
-
University of Central ArkansasCompletedDiabetes Mellitus, Type 2United States
-
Rigshospitalet, DenmarkUnknownIntermittent ClaudicationDenmark
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam UniversityCompletedCardiovascular Disease | Aneurysm | Aortic Aneurysm, Abdominal | Vascular Disease | Aortic DiseaseUnited Kingdom
-
Université de SherbrookeCompleted
-
University of VermontCompletedCancer ThrombosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure, CongestiveUnited States, Canada, France